Aktis Oncology Inc ($AKTS) received 3 mentions from 2 distinct FinTwit voices over a 12-week period starting December 22, 2025. The biotech-focused conversation was led by @jacobplieth with 2 mentions, followed by @aleabitoreddit with 1 mention. Initial discussion centered on the company's IPO valuation and first-day trading performance, while later commentary situated $AKTS within the broader landscape of US government chip funding initiatives, noting the company secured a $4 million lead grant for the "LADDER" project via the NEMC Hub as part of Department of Defense microelectronics programs.